![Christopher B. Curran](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher B. Curran
Directeur/Bestuurslid bij Parent Project Muscular Dystrophy
Oorsprong van het eerstegraads netwerk van Christopher B. Curran
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Parent Project Muscular Dystrophy
![]() Parent Project Muscular Dystrophy Miscellaneous Commercial ServicesCommercial Services Parent Project Muscular Dystrophy focuses on finding a cure for Duchenne muscular dystrophy. The company was founded by Pat Furlong in 1984 and is headquartered in Washington, DC.
21
| Private Company | Miscellaneous Commercial Services | 21 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Christopher B. Curran via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Rochester Christian University | College/University | Doctorate Degree | |
Illinois State University | College/University | Undergraduate Degree | |
University of Mumbai | College/University | Undergraduate Degree | |
Allegheny College | College/University | Undergraduate Degree | |
The National Organization for Rare Disorders, Inc.
![]() The National Organization for Rare Disorders, Inc. Services to the Health IndustryHealth Services The National Organization for Rare Disorders, Inc. operates as a non-profit federation of voluntary health organizations to help individuals with diseases and disorders. Its services are focused on the identification, treatment, and cure of disorders through programs of education, advocacy, research, and service. The company was founded in 1983 and is headquartered in Danbury, CT. | Services to the Health Industry | Director/Board Member | |
University of Wisconsin-Whitewater | College/University | Graduate Degree | |
Renovacor Holdings, Inc.
![]() Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Biotechnology | Chief Operating Officer | |
RENOVACOR, INC. | Biotechnology | Chief Operating Officer |
Statistieken
Internationaal
Verenigde Staten | 9 |
India | 2 |
Sectoraal
Consumer Services | 6 |
Health Technology | 3 |
Health Services | 2 |
Commercial Services | 2 |
Operationeel
Director/Board Member | 20 |
Chief Operating Officer | 3 |
Undergraduate Degree | 3 |
Chief Executive Officer | 2 |
President | 2 |
Sterkste connecties
- Beurs
- Insiders
- Christopher B. Curran
- Bedrijfsconnecties